Watch: California and feds invest in health care for homeless people

KFF Health News senior correspondent Angela Hart appeared on Spectrum News 1’s “Los Angeles Times Today” on Oct. 24 to discuss her coverage of state and federal efforts to expand street medicine — a growing field that focuses on treating homeless people wherever they are, whether indoors or on the streets.

Risk adjusted net present value: What is the current valuation of Johnson & Johnson’s PN-235?

PN-235 is a synthetic peptide commercialized by Johnson & Johnson, with a leading Phase III program in Plaque Psoriasis (Psoriasis Vulgaris).

March 14, 2024

Lawmakers Pan DEA’s Leaked Plans for Telehealth

Legislators who want to see an extension of COVID-era telemedicine flexibilities slammed a draft proposed rule from the Drug Enforcement Administration (DEA) that would curb

October 17, 2024

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Head And Neck Cancer: Likelihood of Approval

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technology and currently in Phase II for Head And Neck Cancer.

April 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.